ro 22-1319 has been researched along with molindone in 1 studies
| Studies (ro 22-1319) | Trials (ro 22-1319) | Recent Studies (post-2010) (ro 22-1319) | Studies (molindone) | Trials (molindone) | Recent Studies (post-2010) (molindone) |
|---|---|---|---|---|---|
| 23 | 3 | 0 | 162 | 30 | 24 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cody, V; Froimowitz, M | 1 |
1 other study(ies) available for ro 22-1319 and molindone
| Article | Year |
|---|---|
The incorporation of butyrophenones and related compounds into a pharmacophore for dopamine D2 antagonists.
Topics: Antipsychotic Agents; Benzimidazoles; Butyrophenones; Dopamine Antagonists; Drug Design; Isoquinolines; Models, Molecular; Molecular Conformation; Molindone; Receptors, Dopamine D2; Spiperone | 1997 |